ORCHARD PARK, NY -- 06/26/07 --
ValueCentric, LLC®, the leading provider
of on-demand data management and performance analytics to the
pharmaceutical industry, today announced that Apotex Corp. has selected the
company's award-winning ValueTrak® solution to forecast and monitor
supply chain movement for its extensive generic product line. Apotex
produces over 260 generic drugs in more than 4,000 dosages and formats and
markets its products in 115 countries worldwide.
Apotex joins over 30 existing ValueCentric customers, and a growing base of
generic manufacturers that selected ValueTrak to analyze sales, inventory,
service levels and supply chain data. In making the announcement, Dave
Janca, ValueCentric's Founder & CEO, commented, "Given the company's
extensive product line, ValueTrak will provide Apotex the ability to view
critical supply chain information at various levels of detail from a total
market perspective, into customer distribution centers and down to outlets
such as retail stores, hospitals and clinics. With an emphasis on exception
management and alerts, the ValueTrak application processes thousands of
daily transactions to present critical information to the Apotex trade
teams, financial executives, market analytics specialists, and sales and
operational managers. Apotex can utilize this information to analyze
product movement, inventories, contract sales and other key financial
metrics."
In naming ValueCentric as their data management and performance analytics
provider, Tammy McIntire, Apotex Corp. President, noted, "ValueTrak's
real-time financial analysis capabilities will allow us to better measure
trading partners' performance and improve business relationships. Most
importantly, ValueTrak will help us to maintain supply chain visibility,
allow us to become more proactive in assessing potential challenges in the
chain, and should positively impact how we plan product movement in the
Apotex supply chain."
"ValueCentric is committed to providing world-class pharmaceutical
companies such as Apotex with the best data analytics and planning platform
the industry has to offer. Given ValueTrak's Sarbanes-Oxley compliant
services, secure on-demand environment, infrastructure efficiencies, rapid
implementation, seamless upgrades and real-time data management, we are
confident that Apotex will see a rapid and measurable return on
investment," Janca added.
About ValueCentric:
ValueCentric, LLC® is the leading provider of on-demand data management
and performance analytics to the pharmaceutical industry. Through its
secure, Sarbanes-Oxley compliant hosted data service, ValueTrak®, the
company analyzes manufacturer's sales, inventory, service levels and supply
chain data. Serving world-class customers such as AstraZeneca, P&G
Pharmaceuticals and Johnson & Johnson, ValueCentric's best-in-class
technology strengthens and enhances the profitability of relationships
between suppliers and the finished goods forward participants in their
supply chain. To learn more, please visit www.valuecentric.com or contact
David Flood, Vice President, Information Services, at 716-667-0297 x103.
About Apotex:
Apotex Corp. is the US Company that markets the product of Apotex, Inc.,
the largest Canadian-owned manufacturer of prescription drugs. Through its
sales and marketing headquarters in Weston, Florida and operations center
in Indianapolis, Apotex Corp. is committed to providing safe and affordable
generic medicines. Products manufactured by Apotex Inc. and marketed by the
Apotex Group are sold in 115 countries around the world. For more
information, visit www.apotexcorp.com.
Contact:
David Flood
Vice President
Information Services
716-667-0297 x103
